|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment charge | |||||
| Loss on lease abandonment | |||||
| Deferred income taxes | |||||
| Non-cash interest | |||||
| Amortization of syndication contracts | |||||
| Payments on syndication contracts | |||||
| Non-cash stock-based compensation | |||||
| (Gain) loss on marketable securities | |||||
| (Gain) loss on disposal of property and equipment | |||||
| Loss (gain) on the sale of businesses | |||||
| (Gain) loss on debt extinguishment | |||||
| Change in fair value of contingent consideration | |||||
| Net income (loss) attributable to redeemable noncontrolling interest - discontinued operations | |||||
| Net income (loss) attributable to noncontrolling interest - discontinued operations | |||||
| Changes in assets and liabilities, net of businesses acquired and disposed of: | |||||
| (Increase) decrease in trade receivables, net | |||||
| (Increase) decrease in prepaid expenses and other current assets, operating leases right of use asset and other assets | |||||
| Increase (decrease) in accounts payable, accrued expenses and other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sale of assets/business, net of cash divested | |||||
| Purchases of property and equipment | |||||
| Purchase of businesses, net of cash acquired | |||||
| Purchases of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Proceeds from loan receivable | |||||
| Purchases of investments | |||||
| Issuance of loan receivable | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from stock option exercises | |||||
| Tax payments related to shares withheld for share-based compensation plans | |||||
| Payments on debt | |||||
| Dividends paid | |||||
| Distributions to noncontrolling interest | |||||
| Repurchase of Class A common stock | |||||
| Payment of contingent consideration | |||||
| Principal payments under finance lease obligation | |||||
| Proceeds from borrowings on debt | |||||
| Payments for debt issuance costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rates on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash: | |||||
| Beginning | |||||
| Ending | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash payments for: | |||||
| Interest | |||||
| Income taxes | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Capital expenditures financed through accounts payable, accrued expenses and other liabilities | |||||
| Fair value of contingent consideration related to acquisitions and purchase of noncontrolling interest | |||||
| Fair value of put and call option | |||||
| Dividends equivalents payable | |||||
Loading...
